Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies [Yahoo! Finance]
OmniAb, Inc. (OABI)
Company Research
Source: Yahoo! Finance
OmniUltra Virtual Investor Event begins at 5:00 p.m. Eastern time today EMERYVILLE, Calif., December 15, 2025 BUSINESS WIRE OmniAb, Inc. (NASDAQ: OABI) announces the launch of its new OmniUltra ™ platform, the industry's first and only transgenic chicken engineered to express ultralong CDRH3 domains on a human antibody framework, at the 2025 Antibody Engineering & Therapeutics (AET) Conference underway in San Diego. OmniUltra is a versatile in vivo discovery platform that extends beyond traditional antibody modalities into the peptide space, enabling multiple therapeutic applications. It generates naturally optimized human immune antibody repertoires featuring cow-inspired ultralong CDRH3 domains, unlocking novel binding modes and access to challenging targets. OmniUltra also enables the isolation of picobodies ™ , the smallest known natural antibody-derived binding domain (4–6 kDa), which are approximately one-third the size of a nanobody ® . OmniUltra is designed to deliver pre
Show less
Read more
Impact Snapshot
Event Time:
OABI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OABI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OABI alerts
High impacting OmniAb, Inc. news events
Weekly update
A roundup of the hottest topics
OABI
News
- OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript [Seeking Alpha]Seeking Alpha
- Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery TechnologiesBusiness Wire
- OmniAb (NASDAQ:OABI) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- OmniAb to Hold OmniUltra Virtual Investor Event on December 15 [Yahoo! Finance]Yahoo! Finance
- OmniAb to Hold OmniUltra Virtual Investor Event on December 15Business Wire
OABI
Earnings
- 11/4/25 - In-Line
OABI
Sec Filings
- 12/9/25 - Form 4
- 12/9/25 - Form 4
- 12/9/25 - Form 4
- OABI's page on the SEC website